BioDlink International Co Ltd (HKSE:01875) Share Price

Company Profile

Business description
BioDlink International Co Ltd is an investment holding company. The Company is mainly engaged in research and development (R&D), manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO), contract manufacturing organization (CMO) business and license-out of self-developed biological drugs. The company has presence in Mainland China, and Others. The company's services includes ADC R&D Service Platform, Chemical based conjugation process development, Developability assessment for drug product, Drug substance analysis, Antibody Manufacturing, Drug product analysis, etc.
Contact
120 Changyang Street
Suzhou Industrial Park
Suzhou215024
CHN
T: +86 51262965186
https://www.biodlink.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
613

Recommended

This REIT remains undervalued as trophy properties shine through.

Yingqi Tan, CFA | 01 July 2026

Why earnings growth might be more important when assessing frothy market conditions.

Damien Klassen | 30 June 2026

This company is unlikely to be disrupted by AI

Roy Van Keulen | 30 June 2026

Index	Last price	Change	% Change
All Ordinaries	8,952.60	50.40	-0.56%
CAC 40	8,403.99	36.66	0.44%
DAX 40	24,995.81	368.92	1.50%
Dow JONES (US)	52,319.20	136.46	0.26%
FTSE 100	10,497.12	12.90	0.12%
HKSE	22,881.02	145.66	-0.63%
NASDAQ	26,213.72	393.58	1.52%
Nikkei 225	70,206.89	144.57	0.21%
NZX 50 Index	13,628.47	6.81	0.05%
S&P 500	7,499.36	58.93	0.79%
S&P/ASX 200	8,742.40	52.20	-0.59%
SSE Composite Index	4,094.40	20.50	0.50%